Bristol-Myers Reports Loss, Hurt by Special Charges

January 24, 2007

Bristol-Myers Squibb Co. reported a fourth-quarter loss on Thursday because of special charges and generic competition for its Plavix blood-clot drug, and results beat expectations because of a tax credit.

*For more on this story,

read the full Reuters article.

Want more from the best local business newspaper in the country?

Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!

Would you like to subscribe to Orange County Business Journal?

One-Year for Only $99

Unlimited access to OCBJ.com
Daily OCBJ Updates delivered via email each weekday morning
Journal issues in both print and digital format
The annual Book of Lists: industry of Orange County's leading companies
Special Features: OC's Wealthiest, OC 500, Best Places to Work, Charity Event Guide, and many more!

Broadcom: In Compliance With Nasdaq

OC Home Dec. Prices Fall, Sales Up From Nov.

staff-author

Bristol-Myers Reports Loss, Hurt by Special Charges

Want more from the best local business newspaper in the country?

Would you like to subscribe to Orange County Business Journal?

Featured Articles

Fusion Company TAE Gets $200M from Trump Group

WM Technology to Voluntarily Delist from Nasdaq

Kura Sushi Reports 23% Increase in Fiscal Q2 Sales; CFO Departs

Related Articles

Fusion Company TAE Gets $200M from Trump Group

WM Technology to Voluntarily Delist from Nasdaq

Kura Sushi Reports 23% Increase in Fiscal Q2 Sales; CFO Departs

UST Acquires Intecrowd

Midday Stock Roundup: Alignment Healthcare rises

Advertise With Us

About Us

Subscriber Links

Other Journals